Home » Stocks » LENSAR, Inc


Stock Price: $8.25 USD -0.33 (-3.85%)
Updated Oct 23, 2020 1:15 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap n/a
Revenue (ttm) 27.48M
Net Income (ttm) -16.47M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $8.25
Previous Close $8.58
Change ($) -0.33
Change (%) -3.85%
Day's Open 8.29
Day's Range 8.00 - 8.60
Day's Volume 10,277
52-Week Range 3.16 - 12.71

More Stats

Market Cap n/a
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding n/a
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue 27.48M
Operating Income n/a
Net Income -16.47M
Free Cash Flow n/a
Net Cash -25.42M
Net Cash / Share n/a
Gross Margin 48.14%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth25.18%-
Gross Profit13.2310.75
Operating Income-12.71-9.32
Net Income-14.66-12.59
Shares Outstanding9.639.63
Earnings Per Share-1.52-1.46
Operating Cash Flow-12.59-1.89
Capital Expenditures-0.39-1.16
Free Cash Flow-12.98-3.04
Cash & Equivalents5.123.82
Total Debt20.536.32
Net Cash / Debt-15.42-2.51
Book Value-30.55-20.47
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name LENSAR, Inc.
Country United States
Employees 75

Stock Information

Ticker Symbol LNSR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: LNSR


LENSAR operates as a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.